Citi's pre-earnings caution: Social media chatter centers on a bearish Citi note ahead of Salesforce's Q1 earnings on May 27. Analysts trimmed FY27 estimates citing longer deal cycles, portfolio optimizations in Tableau and Marketing Cloud, and limited Agentforce scaling so far. Shares have declined 33% year-to-date, fueling debates on near-term growth deceleration.
Bullish value counterpoints: Optimists point to the stock trading at 15x forward earnings with robust FY26 free cash flow and a $25 billion buyback. Guidance for 10-14% revenue growth toward $60 billion by 2030, plus insider purchases, underscores long-term strength. Agentforce's enterprise potential is viewed as a key earnings catalyst.
Earnings watch intensifies: Discussions mix wariness over guidance with hopes for AI-driven surprises. High implied volatility reflects uncertainty, but some see a generational buying opportunity below $180. Overall sentiment remains cautiously optimistic amid SaaS sector rotations.
Note: This discussion summary was generated from an AI condensation of post data.
Salesforce Insider Trading Activity
Salesforce insiders have traded $CRM stock on the open market 11 times in the past 6 months. Of those trades, 5 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $CRM stock by insiders over the last 6 months:
- PARKER HARRIS (Co-Founder and CTO, Slack) has made 0 purchases and 5 sales selling 134,662 shares for an estimated $31,605,031.
- G MASON MORFIT purchased 96,000 shares for an estimated $25,015,680
- DAVID BLAIR KIRK has made 2 purchases buying 4,506 shares for an estimated $1,000,900 and 0 sales.
- NEELIE KROES sold 3,893 shares for an estimated $929,275
- LAURA ALBER has made 2 purchases buying 2,571 shares for an estimated $500,266 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Salesforce Revenue
Salesforce had revenues of $11.2B in Q4 2026. This is an increase of 12.09% from the same period in the prior year.
You can track CRM financials on Quiver Quantitative's CRM stock page.
You can access data on CRM stock through the Quiver Quantitative API.
Salesforce Congressional Stock Trading
Members of Congress have traded $CRM stock 9 times in the past 6 months. Of those trades, 4 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $CRM stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARIA ELVIRA SALAZAR purchased up to $50,000 on 04/06.
- REPRESENTATIVE DAVID TAYLOR has traded it 4 times. They made 2 purchases worth up to $30,000 on 02/09, 01/29 and 2 sales worth up to $65,000 on 02/26.
- REPRESENTATIVE JULIA LETLOW has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 02/02, 12/16.
- SENATOR MARKWAYNE MULLIN purchased up to $50,000 on 12/29.
- SENATOR JOHN BOOZMAN sold up to $15,000 on 11/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
Salesforce Hedge Fund Activity
We have seen 1,256 institutional investors add shares of Salesforce stock to their portfolio, and 1,619 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- J. STERN & CO. LLP added 47,189,352 shares (+24056.7%) to their portfolio in Q4 2025, for an estimated $12,500,931,238
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 25,418,477 shares (-75.2%) from their portfolio in Q4 2025, for an estimated $6,733,608,742
- SANDERS CAPITAL, LLC added 8,615,819 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,282,416,611
- JPMORGAN CHASE & CO removed 6,496,920 shares (-49.8%) from their portfolio in Q4 2025, for an estimated $1,721,099,077
- AMERIPRISE FINANCIAL INC added 3,930,311 shares (+80.5%) to their portfolio in Q4 2025, for an estimated $1,041,178,687
- CARDANO RISK MANAGEMENT B.V. removed 3,487,604 shares (-89.8%) from their portfolio in Q1 2026, for an estimated $650,019,633
- HARRIS ASSOCIATES L P added 2,744,748 shares (+39.0%) to their portfolio in Q4 2025, for an estimated $727,111,192
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Salesforce Analyst Ratings
Wall Street analysts have issued reports on $CRM in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 02/26/2026
- BTIG issued a "Buy" rating on 12/17/2025
- Needham issued a "Buy" rating on 12/04/2025
- BMO Capital issued a "Outperform" rating on 12/04/2025
- Wedbush issued a "Outperform" rating on 12/04/2025
- Baird issued a "Outperform" rating on 12/04/2025
- Citizens issued a "Market Outperform" rating on 12/04/2025
To track analyst ratings and price targets for Salesforce, check out Quiver Quantitative's $CRM forecast page.
Salesforce Price Targets
Multiple analysts have issued price targets for $CRM recently. We have seen 32 analysts offer price targets for $CRM in the last 6 months, with a median target of $257.5.
Here are some recent targets:
- Allan Verkhovski from BTIG set a target price of $255.0 on 04/17/2026
- Billy Fitzsimmons from Piper Sandler set a target price of $215.0 on 04/14/2026
- Nehal Chokshi from Northland Capital Markets set a target price of $229.0 on 03/10/2026
- Tyler Radke from Citigroup set a target price of $200.0 on 03/02/2026
- Gil Luria from DA Davidson set a target price of $200.0 on 02/27/2026
- Parker Lane from Stifel set a target price of $250.0 on 02/26/2026
- Scott Berg from Needham set a target price of $400.0 on 02/26/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
